AKT1 and cancer: The phosphoinositide 3-kinase (PI3K)/Akt/mTOR and mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) oncogenic signaling pathways appeal much attention as they are frequently hyperactivated in cancer, deregulating control of metabolism, cell apoptosis, survival and proliferation11, 12.